उत्पादन वर्णन
Dasatinib, sold under the brand name DYRONIB, is a targeted therapy medication used to treat certain types of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), specifically those that are Philadelphia chromosome-positive, and is taken orally.